Granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralizing antibodies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8609101
APP PUB NO 20100291075A1
SERIAL NO

12766444

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides a GM-CSF neutralizing human monoclonal antibody, 1783J22, as well as methods of making and use thereof. The monoclonal antibody is further characterized by its ability to bind epitopes from GM-CSF proteins of multiple species.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THERACLONE SCIENCES INCSEATTLE LIFE SCIENCES BUILDING 1124 COLUMBIA STREE SUITE 300 SEATTLE WA 98104

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chan-Hui, Po-Ying Bellevue, US 40 603
Cox, Thomas C Redmond, US 16 108
Frey, Steven Redmond, US 18 120
Grandea,, III Andres G Shoreline, US 12 112

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 17, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00